MiNK Therapeutics Inc

MiNK Therapeutics Inc

INKT - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$53.73M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
MiNK Therapeutics IncMiNK Therapeutics Inc-4.4----
$1.92

Current Fair Value

82.5% downside

Overvalued by 82.5% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$53.73 Million
Enterprise Value$-8,753,242,389.00
Earnings per Share$-2.93
Beta0.47
Outstanding Shares5,023,450

Return

Return on EquityNaN%ROE
Return on Assets-188.43%
Return on Invested Capital0.33%

Valuation & Multiples

P/E Ratio-4.41P/E Ratio
PEG16.83PEG
Price to Sales-Price to Sales
Price to Book Ratio0.01Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-1314.41
Enterprise Value to Net Income0
Total Debt to Enterprise0
Debt to Equity-Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
August 13, 2026
EPS Estimate
$-0.60
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Next Earnings Call

Expected Date
November 12, 2026
EPS Estimate
$-0.50
Consensus analyst estimate
Revenue Estimate
$875,000
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %0.00%▼ 4.07%
Total Invested$1,226▼ 99.95%
Investors Holding2▼ 27.00%

About MiNK Therapeutics Inc

MiNK Therapeutics Insider Information FAQ

In the latest 13F quarter on Stockcircle, 2 top investors reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Stockcircle shows 2 open-market insider sales for MiNK Therapeutics in the last six months from SEC Form 4 reports by executives, directors, and other insiders.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.